Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS‐CoV‐2 infection

Mounting evidence supports the importance of mucosal immunity in the immune response to SARS‐CoV‐2. Active virus replication in the upper respiratory tract for the first days of infection opens a new perspective in immunological strategies to counteract viral pathogenicity. An effective mucosal inna...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez‐Argente, Francisco, Alba‐Domínguez, María, Ortiz‐Muñoz, Elena, Ortega‐González, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Discussion Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816245/
https://www.ncbi.nlm.nih.gov/pubmed/32892403
http://dx.doi.org/10.1111/sji.12972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816245/
https://www.ncbi.nlm.nih.gov/pubmed/32892403
http://dx.doi.org/10.1111/sji.12972

Ejemplares similares